Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study

医学 (+)-纳洛酮 药店 协议(科学) 立法 家庭医学 机构审查委员会 医疗急救 类阿片 精神科 替代医学 法学 政治学 受体 病理 内科学
作者
Ana L. Hincapie,Michael Hegener,Pamela C. Heaton,Gabrielle Fish,Kathryn Fetters,Gregory T. Sneed,Kathleen Koechlin,Jolene DeFiore-Hyrmer,Amy Holthusen,Neil J. MacKinnon
出处
期刊:Journal of Addiction Medicine [Lippincott Williams & Wilkins]
卷期号:15 (1): 40-48 被引量:10
标识
DOI:10.1097/adm.0000000000000672
摘要

Objectives: In 2015, the State of Ohio passed legislation to allow pharmacists to dispense naloxone under a physician-approved protocol. The legislation allows all individuals authorized under a physician-approved protocol to personally furnish naloxone without requiring clients to be seen by a licensed prescriber, thus expanding the capacity of Ohio's community distribution programs. We aimed to evaluate the implementation of legislation allowing for a physician-approved protocol in pharmacies and other naloxone distribution sites in Ohio, and to compare barriers and facilitators of implementing the law changes among sites that implemented a physician-approved protocol versus sites that did not. Methods: The study used a convergent parallel mixed-method design. Random samples from all pharmacies registered with the State of Ohio Board of Pharmacy and community naloxone distribution sites were selected. Quantitative data were collected via survey (n = 168) and qualitative data were collected via semi-structured interviews (n = 17). Results: Most survey respondents agreed that the policy has expanded access to naloxone at their site for individuals who want or need the medication. Both pharmacies and other naloxone distribution sites identified that leadership and organizational support facilitated protocol implementation and cost, stigma, and lack of naloxone demand challenged protocol implementation. Conclusions: The study identified barriers and facilitators to the implementation of a physician-approved protocol within Ohio. The majority of respondents stated they could implement a protocol. However, barriers of cost, lack of public awareness of naloxone availability, and stigma remain for pharmacies and other naloxone distribution sites.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
敬敬发布了新的文献求助10
刚刚
Jasper应助辛勤寻凝采纳,获得10
刚刚
1秒前
离线线线发布了新的文献求助10
4秒前
Frost发布了新的文献求助10
4秒前
汉堡包应助yyyy采纳,获得10
4秒前
王人捷应助Leanne采纳,获得10
4秒前
红茶冰可可完成签到 ,获得积分10
6秒前
6秒前
小马甲应助yuhangli采纳,获得10
7秒前
molihuakai应助drxiao采纳,获得20
8秒前
乐观芝麻完成签到,获得积分10
8秒前
redred完成签到,获得积分10
9秒前
10秒前
10秒前
周芷楠完成签到,获得积分10
11秒前
Frost完成签到,获得积分10
12秒前
Keily发布了新的文献求助10
13秒前
15秒前
乐观夜玉完成签到,获得积分10
15秒前
科研通AI6.2应助辛勤寻凝采纳,获得10
15秒前
9700完成签到 ,获得积分10
15秒前
15秒前
如意2023发布了新的文献求助10
16秒前
默默的冷亦完成签到 ,获得积分10
17秒前
wordbob发布了新的文献求助10
17秒前
杨佳完成签到,获得积分10
17秒前
科研通AI2S应助馒头采纳,获得10
18秒前
18秒前
18秒前
19秒前
斯文败类应助科研通管家采纳,获得10
19秒前
研友_VZG7GZ应助科研通管家采纳,获得10
19秒前
无花果应助科研通管家采纳,获得10
19秒前
可爱的函函应助suzhu采纳,获得10
19秒前
共享精神应助科研通管家采纳,获得10
19秒前
852应助科研通管家采纳,获得10
19秒前
Jasper应助科研通管家采纳,获得10
19秒前
Au_应助科研通管家采纳,获得10
20秒前
科目三应助科研通管家采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7322096
求助须知:如何正确求助?哪些是违规求助? 8937463
关于积分的说明 18948446
捐赠科研通 6979933
什么是DOI,文献DOI怎么找? 3214888
关于科研通互助平台的介绍 2382456
邀请新用户注册赠送积分活动 2194144